Reading all the crap about blocking a doctors paper being blocked or not, didn't anyone think that the paper could be held up because the knowledge that is in that paper, (like a poster just posted), could indeed let the cat out of the bag before a regulatory agency approves our molecule or not? What if BP's paper proves what Leronlimab can do in Covid is worthy enough and it puts the fda in a bad position by influencing them either way.

What I am saying is that the paper may be being held up because the fda has to approve Leronlimab is working they way CYDY say's it works and that the fda, as a regulatory agency, can't be made a fool up before they give it a nod and then BP's paper can be approved for publication. This is just my opinion but it can be true - GLTU Sent108 and welcome to the board if it hasn't already been said

HCIT